【摘 要】
:
Anemia associated with chronic renal insufficiency (CRI) may have substantial clinical and public health importance, butlittle is known about its epidemiology.This study aims to quantify the relations
【机 构】
:
Division of Nephrology, University of California, San Francisco, San Francisco,California
【出 处】
:
2013年中国肾性贫血治疗专家共识研讨会
论文部分内容阅读
Anemia associated with chronic renal insufficiency (CRI) may have substantial clinical and public health importance, butlittle is known about its epidemiology.This study aims to quantify the relationship between reduced renal function and hemoglobin level, to assess the iron status of subjects with CRI, and to estimate the burden of anemia associated with CRI.The Third National Health and Nutrition Examination Survey (NHANES Ⅲ) (1988 to 1994) data on 15,971 adults aged >18 yr with measurements of serum creatinine, hemoglobin, and iron profile were analyzed.General linear models were used to determine the relationship between hemoglobin level and Cockcroft-Gault creatinine clearance (CrCl) and to estimate the likelihood of anemiaat different levels of renal function in different demographic subgroups.Sample weights were used to produce weighted regression parameters and population estimates.A statistically significant decrease in hemoglobin was apparent among men starting at CrC1 ≤70 ml/min and among women starting at CrCl ≤50 ml/min.At any given level of CrCl, men had a larger decrease in hemoglobin than women.For example, compared with subjects with CrCl >80 ml/min, the decrease in hemoglobin for subjects with CrC1 20 to 30 ml/min was 1.0 g/dl in women and 1.4 g/dl in men.A substantial number of subjects with CRI might not have sufficient iron stores to support erythropoiesis as judged by the NKF-K/DOQI transferrin saturation or serum ferritin targets.Among those with CrCl 20 to 30 ml/min, 46% of women and 19% of men had transferrin saturation <20%, and 47% of women and 44% of men had serum ferritin <100 ng/ml.Results estimate that 13.5 million US adults had CrCi ≤50 ml/min.The overall burden of CRI associated anemia,defined as hemoglobin <11 g/dl, was 800,000 adults.The public health burden of anemia associated with CRI may be substantial, given the large number of people with CRI; and that even a modest reduction in renal function is associated with decreased hemoglobin level.
其他文献
目的:研究分析髓系抗原(MyAg)表达在急性淋巴细胞白血病(Acute Lymphoblastic Leukemia, ALL)中的表达情况及其与预后的相关性.方法:选择中山大学附属中山医院2001年1月~2010年12月收治的初诊的成人急性淋巴细胞白血病病例共137例,所有患者均进行了骨髓细胞形态学、白血病免疫分型检查及Ph染色体检查,部分患者进行了分子生物学检测,分析髓系抗原在ALL中的表达情
目的:研究不同方案作为伴t(8; 21)急性髓系白血病缓解后的巩固治疗对疾病预后的影响。方法:回顾性分析多中心诊断的诱导缓解后接受≥2疗程巩固治疗的111例伴t(8; 21) AML患者的临床资料,分析不同巩固方案对OS和PFS的影响。结果:(1) 111例患者[男:女=65:46,中位年龄25(2-60)岁]中接受常规方案巩固化疗者(A组)有36例,含DAE、<4程MiDAC、<3程HiDAC强
目的:探讨利妥昔单抗对弥漫大B细胞淋巴瘤患者Th17细胞及相关细胞因子体外的影响及其意义。方法:DLBCL初治患者和体检健康者各20例,每个对象分别采集4份外周血标本,分离外周血单个核细胞(PBMCs),按照培养条件的不同分成4个亚组:空白组(A亚组)、加入利妥昔单抗组(B亚组)、加入利妥昔单抗和血清组(C亚组)和极化组(D亚组)(加IL-6和TGF-β)。
背景和目的:多发性骨髓瘤患者RANKL表达异常增高使RANKL/RANK信号系统过度激活,导致破骨细胞(Osteoclast,oC)大量生成且功能亢进在骨髓瘤骨病(Myeloma bone disease,MBD)的发生、发展中起关键作用,因此抑制RANKL/RANK信号转导途径从而抑制OC的形成及其破骨功能是治疗MBD有效方法之一。前期研究发现RANK蛋白上存在一个新基序:IVVY,介导了一条O
背景反复输血或使用红细胞生成刺激剂(ESA)都可以用于治疗肾性贫血.但是对两种治疗方法的选择,应该针对患者的实际情况,根据两种治疗方法的相对利弊进行选择.单纯的Hb降低不作为输血的理由,不能为了Hb达标而输血.慢性贫血患者输血是为了防止组织缺氧或心力衰竭.在ESA治疗Hb达标的患者,仅在急性失血(如急性出血、急性溶血、严重炎症或外科血液丢失)时输血.输血患者患急性冠脉综合征时有更高的死亡率.使用输
Background.Recent clinical trials in cancer patients treated with erythropoiesis-stimulating agents (ESAs) and in CKD patients treated to haemoglobin (Hb) targets above the labeled range of 10-12 g/dL
Background and Objectives: Instability of hemoglobin levels during epoetin therapy is a new problem in hemodialysis.We evaluated extent and correlates of time in target, that is, the time spent with h
Background: Anaemia is a known risk factor for cardiovascular disease and treating anaemia in chronic kidney disease (CKD) may improve outcomes.However, little is known about the scope to improve prim
Objective-To determine whether recombinant human erythropoietin improves the quality of fife and exercise capacity of anaemic patients receiving haemodialysis.Design-A double blind, randomised, placeb
Haemoglobin (Hgb) levels are known to be associated with numerous adverse outcomes in both chronic kidney disease (CKD) and non-CKD patients.This analysis evaluates the association of baseline haemogl